BHADRESHKUMAR PARIKH: Open Payments
NPI 1093827651 · TAMARAC, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$466 in 23 payments from 6 companies in 2025. Trend: 2023 $486 · 2024 $411 · 2025 $466
Food & beverage: $466
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 11 | $244 |
| Teva Pharmaceuticals USA, Inc. | 6 | $93 |
| Neurocrine BioSciences, Inc. | 3 | $62 |
| Lundbeck LLC | 1 | $29 |
| Alkermes, Inc. | 1 | $20 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
Products named: HETLIOZ, AUSTEDO XR, INGREZZA, FANAPT, REXULTI, LYBALVI, COBENFY.
Industry payments across FL — which companies pay providers there.
